Protective effects of berberine against low-density lipoprotein (LDL) oxidation and oxidized LDL-induced cytotoxicity on endothelial cells

Journal of Agricultural and Food Chemistry

Volumn 55, Issue 25, 2007, Pages 10437-10445

  Hsieh, Yih Shou ^a   Kuo, Wu Hsien ^b   Lin, Ta Wei ^b   Chang, Horng Rong ^c   Lin, Teseng His ^d   Chen, Pei Ni ^a,e   Chu, Shu Chen ^e  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Atherogenesis; Berberine; HUVECs; oxLDL; ROS

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN B; BERBERINE; COPPER; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; LIPID PEROXIDATION; PHYSIOLOGY; UMBILICAL VEIN;

ANTIOXIDANTS; APOLIPOPROTEINS B; APOPTOSIS; BERBERINE; CELLS, CULTURED; COPPER; ENDOTHELIAL CELLS; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; UMBILICAL VEINS;

BERBERIS; COPTIS;

EID: 38049001548     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf071868c     Document Type: Article

References (23)

1. Galassetti, P.; Pontello, A. Dietary effects on oxidation of low-density lipoprotein and atherogenesis. Curr. Atheroscler. Rep. 2006, 8, 523-529.
2. Torzewski, M.; Lackner, K. J. Initiation and progression of atherosclerosis-enzymatic or oxidative modification of low-density lipoprotein. Clin. Chem. Lab. Med. 2006, 44, 1389-1394.
3. Witztum, J. L.; Steinberg, D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 1991, 88, 1785-1792.
4. Chnari, E.; Nikitczuk, J. S.; Wang, J.; Uhrich, K. E.; Moghe, P. V. Engineered polymeric nanoparticles for receptor-targeted blockage of oxidized low density lipoprotein uptake and atherogenesis in macrophages. Biomacromolecules 2006, 7, 1796-1805.
5. Vinson, J. A.; Proch, J.; Bose, P.; Muchler, S.; Taffera, P.; Shuta, D.; Samman, N.; Agbor, G. A. Chocolate is a powerful ex vivo and in vivo antioxidant, an antiatherosclerotic agent in an animal model, and a significant contributor to antioxidants in the European and American Diets. J. Agric. Food Chem. 2006, 54, 8071-8076.
6. Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362, 801-809.
7. Dimmeler, S.; Haendeler, J.; Galle, J.; Zeiher, A. M. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the 'response to injury' hypothesis. Circulation 1997, 95, 1760-1763.
8. Sack, R. B.; Froehlich, J. L. Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins. Infect. Immun. 1982, 35, 471-475.
9. Kuo, C. L.; Chi, C. W.; Liu, T. Y. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett. 2004, 203, 127-137.
10. Nair, G. M.; Narasimhan, S.; Shiburaj, S.; Abraham, T. K. Antibacterial effects of Coscinium fenestratum. Fitoterapia 2005, 76, 585-587.
11. Tang, L. Q.; Wei, W.; Chen, L. M.; Liu, S. Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. J. Ethnopharmacol. 2006, 108, 109-115.
12. Abidi, P.; Chen, W.; Kraemer, F. B.; Li, H.; Liu, J. The medicinal plant goldenseal is a natural LDL-lowering agent with multiple bioactive components and new action mechanisms. J. Lipid Res. 2006, 47, 2134-2147.
13. Brusq, J. M.; Ancellin, N.; Grondin, P.; Guillard, R.; Martin, S.; Saintillan, Y.; Issandou, M. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. J. Lipid Res. 2006, 47, 1281-1288.
14. Kong, W.; Wei, J.; Abidi, P.; Lin, M.; Inaba, S.; Li, C.; Wang, Y.; Wang, Z.; Si, S.; Pan, H.; Wang, S.; Wu, J.; Li, Z.; Liu, J.; Jiang, J. D. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat. Med. 2004, 10, 1344-1351.
15. Peng, P. L.; Hsieh, Y. S.; Wang, C. J.; Hsu, J. L.; Chou, F. P. Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Toxicol. Appl. Pharmacol. 2006, 214, 8-15.
16. Letasiova, S.; Jantova, S.; Cipak, L.; Muckova, M. Berberine- antiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells. Cancer Lett. 2006, 239, 254-262.
17. Mantena, S. K.; Sharma, S. D.; Katiyar, S. K. Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP. Carcinogenesis 2006, 27, 2018-2027.
18. Doggrell, S. A. Berberine - a novel approach to cholesterol lowering. Expert. Opin. Invest. Drugs. 2005, 14, 683-685.
19. Jaffe, E. A.; Nachman, R. L.; Becker, C. G.; Minick, C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 1973, 52, 2745-2756.
20. Havel, R. J.; Eder, H. A.; Bragdon, J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 1955, 34, 1345-1353.
21. Wallin, B.; Rosengren, B.; Shertzer, H. G.; Camejo, G. Lipoprotein oxidation and measurement of thiobarbituric acid reacting substances formation in a single microtiter plate: its use for evaluation of antioxidants. Anal. Biochem. 1993, 208, 10-15.
22. Miyakawa, H.; Honma, K.; Qi, M.; Kuramitsu, H. K. Interaction of Porphyromonas gingivalis with low-density lipoproteins: implications for a role for periodontitis in atherosclerosis. J. Periodontal Res. 2004, 39, 1-9.
23. Lee, M. J.; Chou, F. P.; Tseng, T. H.; Hsieh, M. H.; Lin, M. C.; Wang, C. J. Hibiscus protocatechuic acid or esculetin can inhibit oxidative LDL induced by either copper ion or nitric oxide donor. J. Agric. Food Chem. 2002, 50, 2130-2136.